Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
Published March 13, 2024 · Recall initiated: February 20, 2024
Summary
FDA records drug Class II recall D-0366-2024, published March 13, 2024 and initiated February 20, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 10,080 vials; Lot: Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if METHYLPREDNISOLONE ACETATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METHYLPREDNISOLONE ACETATE
- Manufacturer
- Eugia US LLC
- Distributor
- OH, TN, LA, MS
- UPC
- 0355150313013
- Lot
- Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-DoseMay 22, 2024
- FDAClindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse PharmaceuticalsMarch 13, 2024
- FDAMercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottleMarch 13, 2024
- FDAClindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: MarlexMarch 13, 2024
- FDAFrothy Monkey - Plain Croissant - packaged and sold individuallyMarch 13, 2024
- FDALINK BiMobile Dual Mobility System E-Poly Liner for 28mm Head, 70mm Shell- Indicated for patients withMarch 6, 2024
Questions about this recall
Was Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01 recalled?
Yes. FDA published recall D-0366-2024 on March 13, 2024. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METHYLPREDNISOLONE ACETATE. UPC: 0355150313013.